JP2024537398A5 - - Google Patents

Info

Publication number
JP2024537398A5
JP2024537398A5 JP2024522502A JP2024522502A JP2024537398A5 JP 2024537398 A5 JP2024537398 A5 JP 2024537398A5 JP 2024522502 A JP2024522502 A JP 2024522502A JP 2024522502 A JP2024522502 A JP 2024522502A JP 2024537398 A5 JP2024537398 A5 JP 2024537398A5
Authority
JP
Japan
Application number
JP2024522502A
Other languages
Japanese (ja)
Other versions
JPWO2023060359A5 (https=
JP2024537398A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2022/051517 external-priority patent/WO2023060359A1/en
Publication of JP2024537398A publication Critical patent/JP2024537398A/ja
Publication of JPWO2023060359A5 publication Critical patent/JPWO2023060359A5/ja
Publication of JP2024537398A5 publication Critical patent/JP2024537398A5/ja
Pending legal-status Critical Current

Links

JP2024522502A 2021-10-16 2022-10-14 SARS-CoV-2を標的とする改変されたMultabody構築物、組成物、及び方法 Pending JP2024537398A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163256565P 2021-10-16 2021-10-16
US63/256,565 2021-10-16
PCT/CA2022/051517 WO2023060359A1 (en) 2021-10-16 2022-10-14 Modified multabody constructs, compositions, and methods targeting sars-cov-2

Publications (3)

Publication Number Publication Date
JP2024537398A JP2024537398A (ja) 2024-10-10
JPWO2023060359A5 JPWO2023060359A5 (https=) 2025-10-22
JP2024537398A5 true JP2024537398A5 (https=) 2025-10-22

Family

ID=85987097

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024522502A Pending JP2024537398A (ja) 2021-10-16 2022-10-14 SARS-CoV-2を標的とする改変されたMultabody構築物、組成物、及び方法

Country Status (5)

Country Link
US (1) US20250011397A1 (https=)
EP (1) EP4416189A4 (https=)
JP (1) JP2024537398A (https=)
CA (1) CA3235530A1 (https=)
WO (1) WO2023060359A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69434520T3 (de) 1993-07-30 2009-10-15 Affymax, Inc., Palo Alto Biotinylierung von proteinen
DE10113776B4 (de) 2001-03-21 2012-08-09 "Iba Gmbh" Isoliertes streptavidinbindendes, kompetitiv eluierbares Peptid, dieses umfassendes Fusionspeptid, dafür codierende Nukleinsäure, Expressionsvektor, Verfahren zur Herstellung eines rekombinanten Fusionsproteins und Verfahren zum Nachweis und/oder zur Gewinnung des Fusionsproteins
EP1452601A1 (en) 2003-02-28 2004-09-01 Roche Diagnostics GmbH Enhanced expression of fusion polypeptides with a biotinylation tag
JP2022543070A (ja) * 2019-08-01 2022-10-07 ザ ホスピタル フォー シック チルドレン 多価及び多重特異性ナノ粒子プラットフォーム及び方法
AU2022212978A1 (en) * 2021-01-28 2023-08-31 The Hospital For Sick Children Multabody constructs, compositions, and methods

Similar Documents

Publication Publication Date Title
JP2024504777A5 (https=)
BR102022025291A2 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13149U (https=)
BY13159U (https=)
BY13140U (https=)
BY13141U (https=)
BY13142U (https=)
BY13143U (https=)
BY13144U (https=)
BY13145U (https=)
BY13164U (https=)